105
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Evidence-Based Framework and Implementation of China’s Strategy in Combating COVID-19

ORCID Icon, &
Pages 1989-1998 | Published online: 07 Oct 2020

References

  • Chung RY-N, Li MM. Anti-Chinese sentiment during the 2019-nCoV outbreak. Lancet. 2020;395(10225):686–687. doi:10.1016/S0140-6736(20)30358-532122469
  • Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China —Key questions for impact assessment. N Engl J Med. 2020;382:692–694. doi:10.1056/NEJMp200092931978293
  • Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi:10.1002/jmv.2568131967327
  • Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045
  • Kock RA, Karesh WB, Veas F, et al. 2019-nCoV in context: lessons learned? Lancet Planet Health. 2020;4(3):e87–e88. doi:10.1016/S2542-5196(20)30035-832035507
  • Zhang J, Zhou L, Yang Y, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Resp Med. 2020;8(3):e11–e12. doi:10.1016/S2213-2600(20)30071-0
  • Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8:e488–e496. doi:10.1016/S2214-109X(20)30074-732119825
  • Mahase E. China coronavirus: mild but infectious cases may make it hard to control outbreak, report warns. BMJ. 2020;368:m325. doi:10.1136/bmj.m32531992570
  • Horton R. Offline: 2019-nCoV—“A desperate plea”. Lancet. 2020;395(10222):400. doi:10.1016/S0140-6736(20)30299-332035537
  • World Health Organization. WHO coronavirus disease (COVID-19) dashboard; 2020 Available from: https://covid19.who.int/region/wpro/country/cn. Accessed 414, 2020.
  • Ji JS. Origins of MERS-CoV, and lessons for 2019-nCoV. Lancet Planet Health. 2020;4(3):e93. doi:10.1016/S2542-5196(20)30032-232007135
  • Mahase E. China coronavirus: what do we know so far? BMJ. 2020;368:m308. doi:10.1136/bmj.m30831980434
  • Burki TK. Coronavirus in China. Lancet Resp Med. 2020;8(3):238. doi:10.1016/S2213-2600(20)30056-4
  • Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. doi:10.1016/S0140-6736(20)30360-332151335
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
  • Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936. doi:10.1056/NEJMoa200119132004427
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa200131631995857
  • World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19); 2020 Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf?sfvrsn=fce87f4e. Accessed 414, 2020.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.158532031570
  • Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-931986257
  • Chang D, Xu H, Rebaza A, et al. Protecting health-care workers from subclinical coronavirus infection. Lancet Resp Med. 2020;8(3):e13. doi:10.1016/S2213-2600(20)30066-7
  • Zhang H. Early lessons from the frontline of the 2019-nCoV outbreak. Lancet. 2020;395(10225):687. doi:10.1016/S0140-6736(20)30356-132059798
  • Kavanagh MM. Authoritarianism, outbreaks, and information politics. Lancet Public Health. 2020;5(3):e135–e136. doi:10.1016/S2468-2667(20)30030-X32061319
  • Yan J, Zhao D. Administrative mechanism of joint participation and cooperation in the early stages of the COVID-19 outbreak in Wuhan. Risk Manag Healthc Policy. 2020;13:723–731. doi:10.2147/RMHP.S25138932753985
  • Kim J-H, An JA-R, Min P-K, et al. How South Korea responded to the COVID-19 outbreak in Daegu. NEJM Catalyst. 2020;1:4. doi:10.1056/CAT.20.0159
  • Giordano G, Blanchini F, Bruno R, et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat Med. 2020;26(6):855–860. doi:10.1038/s41591-020-0883-732322102
  • Cohen J, Kupferschmidt K. Countries test tactics in ‘war’ against COVID-19. Sci. 2020;367(6484):1287–1288. doi:10.1126/science.367.6484.1287
  • López L, Rodó X. The end of social confinement and COVID-19 re-emergence risk. Nat Hum Behav. 2020;4(7):746–755. doi:10.1038/s41562-020-0908-832572175
  • Campbell JR, Johnston JC, Cook VJ, et al. Cost-effectiveness of latent tuberculosis infection screening before immigration to low-incidence countries. Emerg Infect Dis. 2019;25(4):661–671. doi:10.3201/eid2504.17163030882302
  • Cipriano LE, Zaric GS, Holodniy M, et al. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS One. 2012;7(9):e45176. doi:10.1371/journal.pone.004517623028828
  • Fisher D, Wilder-Smith A. The global community needs to swiftly ramp up the response to contain COVID-19. Lancet. 2020;395(10230):1109–1110. doi:10.1016/S0140-6736(20)30679-632199470